Spiramycin: Difference between revisions
m Protected "Spiramycin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
| Line 24: | Line 24: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
'''Spiramycin''' is a [[macrolide]] antibiotic. It is used to treat [[toxoplasmosis]]. Although routinely used in Europe, spiramycin is still considered an experimental drug in the United States.<ref>[http://www.mayoclinic.com/health/toxoplasmosis/DS00510/DSECTION=8 Toxoplasmosis] at MayoClinic.com</ref> | '''Spiramycin''' is a [[macrolide]] antibiotic. It is used to treat [[toxoplasmosis]]. Although routinely used in Europe, spiramycin is still considered an experimental drug in the United States.<ref>[http://www.mayoclinic.com/health/toxoplasmosis/DS00510/DSECTION=8 Toxoplasmosis] at MayoClinic.com</ref> | ||
| Line 39: | Line 39: | ||
[[Category:Macrolide antibiotics]] | [[Category:Macrolide antibiotics]] | ||
[[pl:Spiramycyna]] | [[pl:Spiramycyna]] | ||
Revision as of 16:13, 20 August 2012
| File:Spyramycin.png | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C43H74N2O14 |
| Molar mass | 843.053 g/mol |
|
WikiDoc Resources for Spiramycin |
|
Articles |
|---|
|
Most recent articles on Spiramycin |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Spiramycin at Clinical Trials.gov Clinical Trials on Spiramycin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Spiramycin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Spiramycin Discussion groups on Spiramycin Patient Handouts on Spiramycin Directions to Hospitals Treating Spiramycin Risk calculators and risk factors for Spiramycin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Spiramycin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Spiramycin is a macrolide antibiotic. It is used to treat toxoplasmosis. Although routinely used in Europe, spiramycin is still considered an experimental drug in the United States.[1]
Used in Europe since 2000 year in name "Rovamycine", produced by Rhone-Poulenc Rorer, France and Eczacibasi Ilae, Turkey.
References
- ↑ Toxoplasmosis at MayoClinic.com
- Pages with script errors
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Macrolide antibiotics